The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Nonpharmaceutical Interventions Implemented by US Cities During the 1918-1919 Influenza Pandemic
Abstract
CONTEXT: A critical question in pandemic influenza planning is the role nonpharmaceutical interventions might play in delaying the temporal effects of a pandemic, reducing the overall and peak attack rate, and reducing the number of cumulative deaths. Such measures could potentially provide valuable time for pandemic-strain vaccine and antiviral medication production and distribution. Optimally, appropriate implementation of nonpharmaceutical interventions would decrease the burden on health care services and critical infrastructure. OBJECTIVES: To examine the implementation of nonpharmaceutical interventions for epidemic mitigation in 43 cities in the continental United States from September 8, 1918, through February 22, 1919, and to determine whether city-to-city variation in mortality was associated with the timing, duration, and combination of nonpharmaceutical interventions; altered population susceptibility associated with prior pandemic waves; age and sex distribution; and population size and density. DESIGN AND SETTING: Historical archival research, and statistical and epidemiological analyses. Nonpharmaceutical interventions were grouped into 3 major categories: school closure; cancellation of public gatherings; and isolation and quarantine. MAIN OUTCOME MEASURES: Weekly excess death rate (EDR); time from the activation of nonpharmaceutical interventions to the first peak EDR; the first peak weekly EDR; and cumulative EDR during the entire 24-week study period. RESULTS: There were 115,340 excess pneumonia and influenza deaths (EDR, 500/100,000 population) in the 43 cities during the 24 weeks analyzed. Every city adopted at least 1 of the 3 major categories of nonpharmaceutical interventions. School closure and public gathering bans activated concurrently represented the most common combination implemented in 34 cities (79%); this combination had a median duration of 4 weeks (range, 1-10 weeks) and was significantly associated with reductions in weekly EDR. The cities that implemented nonpharmaceutical interventions earlier had greater delays in reaching peak mortality (Spearman r = -0.74, P < .001), lower peak mortality rates (Spearman r = 0.31, P = .02), and lower total mortality (Spearman r = 0.37, P = .008). There was a statistically significant association between increased duration of nonpharmaceutical interventions and a reduced total mortality burden (Spearman r = -0.39, P = .005). CONCLUSIONS: These findings demonstrate a strong association between early, sustained, and layered application of nonpharmaceutical interventions and mitigating the consequences of the 1918-1919 influenza pandemic in the United States. In planning for future severe influenza pandemics, nonpharmaceutical interventions should be considered for inclusion as companion measures to developing effective vaccines and medications for prophylaxis and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The environment and disease: association or causation?
Hill, A. B. (2015) · Journal of the Royal Society of Medicine · doi:10.1177/0141076814562718 · Cited by 7,285
The Environment and Disease: Association or Causation?
Hill, A. B. (1965) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576505800503 · Cited by 6,974
Strategies for mitigating an influenza pandemic
Ferguson, N. M., Cummings, D. A. T., Fraser, C., Cajka, J. C., Cooley, P. C., & Burke, D. S. (2006) · Nature · doi:10.1038/nature04795 · Cited by 2,187
Strategies for containing an emerging influenza pandemic in Southeast Asia
Ferguson, N. M., Cummings, D. A. T., Cauchemez, S., Fraser, C., Riley, S., Meeyai, A., Iamsirithaworn, S., & Burke, D. S. (2005) · Nature · doi:10.1038/nature04017 · Cited by 1,816
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.050979 · Cited by 1,686
1918 Influenza: the Mother of All Pandemics
Taubenberger, J. K., & Morens, D. M. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1209.05-0979 · Cited by 1,590
Rosen, G. (1958) · MD Publications eBooks · doi:10.1037/11322-000 · Cited by 1,192
Containing Pandemic Influenza at the Source
Longini, I. M., Nizam, A., Xu, S., Ungchusak, K., Hanshaoworakul, W., Cummings, D. A. T., & Halloran, M. E. (2005) · Science · doi:10.1126/science.1115717 · Cited by 1,163
Characterization of the 1918 influenza virus polymerase genes
Taubenberger, J. K., Reid, A. H., Lourens, R. M., Wang, R., Jin, G., & Fanning, T. G. (2005) · Nature · doi:10.1038/nature04230 · Cited by 1,066
Mitigation strategies for pandemic influenza in the United States
Germann, T. C., Kadau, K., Longini, I. M., & Macken, C. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601266103 · Cited by 1,047
The effect of public health measures on the 1918 influenza pandemic in U.S. cities
Bootsma, M. C. J., & Ferguson, N. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611071104 · Cited by 798
Transmissibility of 1918 pandemic influenza
Mills, C. E., Robins, J. M., & Lipsitch, M. (2004) · Nature · doi:10.1038/nature03063 · Cited by 796
Public health interventions and epidemic intensity during the 1918 influenza pandemic
Hatchett, R. J., Mecher, C. E., & Lipsitch, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610941104 · Cited by 778
Initial Genetic Characterization of the 1918 “Spanish” Influenza Virus
Taubenberger, J. K., Reid, A. H., Krafft, A. E., Bijwaard, K. E., & Fanning, T. G. (1997) · Science · doi:10.1126/science.275.5307.1793 · Cited by 715
Murray, C. J., Lopez, A. D., Chin, B., Feehan, D., & Hill, K. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69895-4 · Cited by 605
The 1918 Influenza Pandemic: Insights for the 21st Century
Morens, D. M., & Fauci, A. S. (2007) · The Journal of Infectious Diseases · doi:10.1086/511989 · Cited by 536
Targeted Social Distancing Designs for Pandemic Influenza
Glass, R. J., Glass, L. M., Beyeler, W. E., & Min, H. J. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1211.060255 · Cited by 525
Nonpharmaceutical Interventions for Pandemic Influenza, National and Community Measures
World Health Organization Writing Group (2012) · Emerging Infectious Diseases · doi:10.3201/eid1201.051371 · Cited by 470
Nonpharmaceutical Interventions for Pandemic Influenza, International Measures
World Health Organization Writing Group (2006) · Emerging Infectious Diseases · doi:10.3201/eid1201.051370 · Cited by 326
America's Forgotten Pandemic: The Influenza of 1918
Chin, T. D. Y., & Crosby, A. W. (1991) · Journal of Public Health Policy · doi:10.2307/3342507 · Cited by 275
America's forgotten pandemic: the influenza of 1918
(2004) · Choice Reviews Online · doi:10.5860/choice.41-3471 · Cited by 206
Quarantine! East European Jewish Immigrants and the New York City Epidemics of 1892
Hinthorn, D. R. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-10-199711150-00022 · Cited by 165
Public Health Strategies for Pandemic Influenza: Ethics and the Law
Gostin, L. O. (2006) · JAMA · doi:10.1001/jama.295.14.1700 · Cited by 164
1918 Influenza Pandemic Caused by Highly Conserved Viruses with Two Receptor-Binding Variants
Reid, A. H., Janczewski, T. A., Lourens, R. M., Elliot, A. J., Daniels, R. S., Berry, C. L., OXFORD, J. S., & Taubenberger, J. K. (2003) · Emerging infectious diseases · doi:10.3201/eid0910.020789 · Cited by 141
(1928) · JAMA · doi:10.1001/jama.1928.02690450083037 · Cited by 139
Disease Mitigation Measures in the Control of Pandemic Influenza
Inglesby, T. V., Nuzzo, J. B., O’Toole, T., & Henderson, D. A. (2006) · Biosecurity and Bioterrorism Biodefense Strategy Practice and Science · doi:10.1089/bsp.2006.4.366 · Cited by 120
(1928) · Archives of Internal Medicine · doi:10.1001/archinte.1928.00130180159013 · Cited by 71
Frost, W. H. (1919) · Public Health Reports (1896-1970) · doi:10.2307/4575271 · Cited by 52
Mortality from Influenza and Pneumonia in 50 Large Cities of the United States, 1910-1929
Collins, S. D., Frost, W. H., Gover, M., & Sydenstricker, E. (1930) · Public Health Reports (1896-1970) · doi:10.2307/4579795 · Cited by 51
Preliminary Statistics of the Influenza Epidemic
Sydenstricker, E. (1918) · Public Health Reports (1896-1970) · doi:10.2307/4574973 · Cited by 29
Variations in Case Fatality during the Influenza Epidemic of 1918
Sydenstricker, E. (1921) · Public Health Reports (1896-1970) · doi:10.2307/4576118 · Cited by 9
GROSS PATHOLOGY OF EPIDEMIC INFLUENZA AT WALTER REED GENERAL HOSPITAL
Lyon, M. W. (1919) · JAMA · doi:10.1001/jama.1919.02610130018006 · Cited by 7
Cited by
Pandemics, tourism and global change: a rapid assessment of COVID-19
Gössling, S., Scott, D., & Hall, C. M. (2021) · Journal of Sustainable Tourism · doi:10.1080/09669582.2020.1758708 · Cited by 4,766
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials
Du, X., Zhou, J., Shi, J., & Xu, B. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00299 · Cited by 1,861
The Unprecedented Stock Market Reaction to COVID-19
Baker, S. R., Bloom, N., Davis, S. J., Kost, K., Sammon, M., & Viratyosin, T. (2020) · The Review of Asset Pricing Studies · doi:10.1093/rapstu/raaa008 · Cited by 1,496
Effect of non-pharmaceutical interventions to contain COVID-19 in China
Lai, S., Ruktanonchai, N. W., Zhou, L., Prosper, O., Luo, W., Floyd, J. R., Wesolowski, A., Santillana, M., Zhang, C., Du, X., et al. (2020) · Nature · doi:10.1038/s41586-020-2293-x · Cited by 1,375
Metadata
- Authors
- Markel, H., Lipman, H. B., Navarro, J. A., Sloan, A., Michalsen, J. R., Stern, A. M., & Cetron, M. S.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2007-08-08
- Volume
- 298
- Issue
- 6
- Pages
- 644
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2129089656
- Cited by
- 777
- References
- 32
- FWCI
- 27.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.